BENDHEIM JACK (President and CEO) sold 24.9% of their position (18.61K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.02M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
−6.26K
Price / share
$55.73
Trade value
$349.07K
% of position
Class A Common Stock
Shares
−776.00
Price / share
$56.37
Trade value
$43.74K
% of position
Class A Common Stock
Shares
−5.63K
Price / share
$57.18
Trade value
$322.13K
% of position
Class A Common Stock
Shares
−1.41K
Price / share
$58.13
Trade value
$81.72K
% of position
Class A Common Stock
Shares
−1.35K
Price / share
$47.59
Trade value
$64.25K
% of position
Class A Common Stock
Shares
−1.15K
Price / share
$48.31
Trade value
$55.51K
% of position
Class A Common Stock
Shares
−2.03K
Price / share
$49.19
Trade value
$99.82K
% of position
Net shares
−18.61K
Net value
-$1.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 5/5/2026 | S · Sale | −6.26K | $55.73 | $349.07K | 8.4% | 74.76K | 68.50K |
| Class A Common Stock Indirect | 5/5/2026 | S · Sale | −776.00 | $56.37 | $43.74K | 1.1% | 68.50K | 67.72K |
| Class A Common Stock Indirect | 5/6/2026 | S · Sale | −5.63K | $57.18 | $322.13K | 8.3% | 67.72K | 62.09K |
| Class A Common Stock Indirect | 5/6/2026 | S · Sale | −1.41K | $58.13 | $81.72K | 2.3% | 62.09K | 60.68K |
| Class A Common Stock Indirect | 5/7/2026 | S · Sale | −1.35K | $47.59 | $64.25K | 2.2% | 60.68K | 59.33K |
| Class A Common Stock Indirect | 5/7/2026 | S · Sale | −1.15K | $48.31 | $55.51K | 1.9% | 59.33K | 58.18K |
| Class A Common Stock Indirect | 5/7/2026 | S · Sale | −2.03K | $49.19 | $99.82K | 3.5% | 58.18K | 56.15K |
| Total | −18.61K | -$1.02M | ||||||
Class A Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |